Nautilus Biotechnology
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$63,675,000 over the previous period. Total operating expenses were $76,152,000.

Profit Margin

Nautilus Biotechnology, Inc. (NASDAQ:NAUT): Profit margin
2018 0 626.6M
2019 0 -9.61K
2020 0 -15.61M
2021 0 -50.31M
2022 0 -63.74M
2023 0 -63.67M

NAUT Income Statement (2018 – 2023)

2023 2022 2021 2020 2019 2018
Revenue
Revenue
000000
Cost of revenue
5.70M3.41M2.84M2.34M00
Gross profit
-5.70M-3.41M-2.84M-2.34M00
Operating exp.
Research and development
47.25M37.67M29.35M12.43M8.48K0
Selling and marketing
000000
Total operating expenses
76.15M63.61M50.49M15.74M9.61K111.68M
Operating income
-76.15M-63.61M-50.49M-15.74M-10.11K-111.68M
Other income (expenses), net
12.47M5.69M183K125K492738.28M
Income before tax
-63.67M-57.92M-50.31M-15.61M-9.61K626.6M
Income tax expense
05.81M02.13M00
Net income
-63.67M-63.74M-50.31M-15.61M-9.61K626.6M
Earnings per share
Basic EPS
-0.51-0.51-0.6-0.52-0.0087.18
Diluted EPS
-0.51-0.51-0.6-0.52-0.0087.18
Data sourceData sourceData sourceData sourceData sourceData source